Cut through the noise with The Intercept’s reporters as they tackle the most urgent issues of the moment. The Briefing is a new weekly podcast delivering incisive political analysis and deep investigative reporting, hosted by The Intercept’s journalists and contributors including Jessica Washington, Akela Lacy, and Jordan Uhl. Hosted on Acast. See acast.com/privacy for more information.
…
continue reading
MP3•Episode home
Manage episode 516161390 series 2793334
Content provided by Libby Znaimer and Zoomer Podcast Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Libby Znaimer and Zoomer Podcast Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
RECOVERING POLITICIANS: PREMIER DOUG FORD'S REAGAN AD AND PRESIDENT TRUMP INCREASES TARIFFS ON CANADA Libby Znaimer is joined by George Smitherman, former Liberal MPP for Toronto Centre, Health Minister and Deputy Premier; Cheri DiNovo, a former NDP MPP; and Lisa Raitt, a former Deputy Leader of Conservative Party of Canada. Ontario Premier Doug Ford feels as though he accomplished his mission with the $75 million anti-tariff Reagan ad that aired in the U.S. and led President Donald Trump not only to end trade talks with Canada but also add an additional 10 percent on tariffs. What do you think about the ad? Was it worth it? WHY DOES PREMIER FORD WANT TO DO AWAY WITH FIXED ELECTION DATES? Libby Znaimer is joined by Duff Conacher, Co-founder of Democracy Watch. The Ford government wants to see an end to fixed election dates? The governing PCs also want to increase the limit for political donations. Duff weighs in on the latest. THE PROMISE OF A NEW HEALTH CANADA APPROVED AZLHEIMER'S DRUG Libby Znaimer is joined by Dr. Sharon Cohen, Medical Director of the Toronto Memory Program. She worked on the lecanemab clinical trials. Dr. Cohen talks about the promise of lecanemab, a drug just approved by Health Canada that works to slow the progression of Alzheimer’s and why it is a game changer. She also addresses concerns around the high cost of the drug and potential side effects.
…
continue reading
501 episodes